pamiparib

BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors
CP Wire
Mon, 10/22/18 - 10:43 am
BeiGene
pamiparib
solid tumors
BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors
Mon, 10/22/18 - 10:01 am
BeiGene
pamiparib
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
CP Wire
Thu, 05/17/18 - 12:03 pm
BeiGene
pamiparib
ovarian cancer
China
clinical trials
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
Thu, 05/17/18 - 09:53 am
BeiGene
pamiparib
ovarian cancer